Alpha Crest Capital Management LLC Aerie Pharmaceuticals Inc Transaction History

Alpha Crest Capital Management LLC

  • $0
  • Q4 2022

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021
SELL
$9.12 - $14.49 $247,799 - $393,707
-27,171 Closed
0 $0
Q3 2020

Nov 12, 2020
BUY
$10.46 - $14.46 $113,302 - $156,630
10,832 Added 66.3%
27,171 $320,000
Q2 2020

Aug 12, 2020
BUY
$12.0 - $16.13 $196,068 - $263,548
16,339 New
16,339 $241,000
Q3 2019

Nov 12, 2019
SELL
$18.41 - $28.0 $299,825 - $456,008
-16,286 Closed
0 $0
Q2 2019

Aug 12, 2019
BUY
$28.97 - $48.21 $471,805 - $785,148
16,286 New
16,286 $481,000

Others Institutions Holding AERI

# of Institutions
3
Shares Held
2.4M
Call Options Held
0
Put Options Held
0
View Full List

About AERIE PHARMACEUTICALS INC

AERI Quotes by TradingView
  • Ticker AERI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,390,500
  • Description
  • Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...
More about AERI
Track This Portfolio

Track Alpha Crest Capital Management LLC Portfolio

Follow Alpha Crest Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Crest Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email